Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Illumina, Inc.

ILMNNASDAQ
Healthcare
Medical - Diagnostics & Research
$120.54
$2.87(2.44%)
U.S. Market opens in 12h 22m

Illumina, Inc. (ILMN) Stock Overview

Explore Illumina, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap18.4B
P/E Ratio21.38
EPS (TTM)$5.45
ROE0.35%
Fundamental Analysis

AI Price Forecasts

1 Month$97.97
3 Months$70.17
1 Year Target$86.49

ILMN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Illumina, Inc. (ILMN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 38.58, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $86.49.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 21.38 and a market capitalization of 18.4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
2.44%
5-Day Change
3.75%
1-Month Change
-19.79%
3-Month Change
-2.67%
6-Month Change
18.41%
Year-to-Date (YTD) Change
-10.28%
1-Year Change
28.29%
3-Year Change
-38.66%
5-Year Change
-73.30%
All-Time (Max) Change
533.42%

Contact Information

858 202 4500
5200 Illumina Way, San Diego, CA, 92122

Company Facts

89,700 Employees
IPO DateJul 28, 2000
CountryUS
Actively Trading

Frequently Asked Questions